Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Canaccord Genuity Group Inc (OP: CCORF ) 6.240 -0.000 (-0.00%) Streaming Delayed Price Updated: 11:12 AM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Canaccord Genuity Group Inc Leading US Cannabis Operator Gets Buy Rating Amid Strategic Divestment And Growth Initiative August 26, 2024 Canaccord Genuity gives Cannabist Company Holdings a Buy rating. Discover how strategic divestments support their growth. Read now! Via Benzinga Topics Cannabis Exposures Cannabis Tesla Sentiment Is Reaching a Tipping Point April 01, 2024 Here's everything you need to know about the electric vehicle maker's week. Via The Motley Fool Topics Electric Vehicles Exposures Electric Vehicles Why NuScale Power Stock Keeps Going Down March 20, 2024 The stock has potential -- if the company can survive long enough. Via The Motley Fool Fission Uranium Announces Funding For Uranium Project In Saskatchewan February 06, 2024 Fission Uranium is raising millions to fund exploration and development activities at its Saskatchewan, Canada-based project. Via Benzinga A Bull Market Is Coming: 2 Top Growth Stocks to Buy Before They Shoot 31% and 47% Higher, According to Wall Street Analysts December 05, 2023 Find out why investment bank analysts are pounding the table on these stocks. Via The Motley Fool Why Braze Stock Soared Today June 09, 2023 This small company delivered a big revenue surprise. Via The Motley Fool Why Quipt Home Medical Stock Got Rocked Today April 18, 2023 The company goes to the investor well for fresh capital. Via The Motley Fool Aurora Cannabis Upsizes Bought Deal Financing May 27, 2022 Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB), has amended the terms of its previously announced bought deal financing. Via Benzinga Deere Stock: Bull vs. Bear October 01, 2023 Is now a good time to plant this farming machinery leader in your portfolio? Via The Motley Fool Why BioXcel Therapeutics Stock Flopped Again Today August 15, 2023 Major changes are afoot with the company, and few are happy about them. Via The Motley Fool A Bull Market Is Coming: 1 Supercharged Growth Stock to Buy Hand Over Fist Before It Soars 113%, According to Wall Street April 05, 2023 This stock has been beaten down by macroeconomic conditions but could rebound big-time if analysts are right. Via The Motley Fool Save Your Struggling Cannabis Business: Canaccord Genuity's Managing Director Has Some Valuable Advice March 15, 2023 The Benzinga Cannabis Capital Conference, the world's largest gathering of cannabis decision-makers, founders, investors and advocates is returning to Miami Beach, Florida on April 11-12, 2023 and... Via Benzinga Agrify Secures $15M Via Its At-The-Market Equity Program October 28, 2022 Agrify Corporation (NASDAQ: AGFY) provided an update on sales under its at-the-market equity program, which was established on October 18, 2022 with Canaccord Genuity (OTCPK:CCORF) serving as the sales... Via Benzinga Why Shares of Plug Power Are Sinking Today October 24, 2022 Wall Street's skepticism continues to feed Main Street's fears about this growth stock's prospects. Via The Motley Fool 1 Small Chip Company Making Serious Dough From Electric Vehicles October 21, 2022 Aehr Test Systems is blowing away financial expectations, but can it last? Via The Motley Fool Zynerba Pharmaceuticals R&D Expenses Reach $5.1M For Q1 2022, Here Are The Details May 16, 2022 Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), reported financial results for the first quarter ended March 31, 2022, revealing net loss of $8.5 million. Via Benzinga HEXO Launches New At-the-Market Offering, Here Are The Details May 03, 2022 HEXO Corp. (NASDAQ: HEXO) (TSX:HEXO) has established an at-the-market equity program that allows the company to issue and sell up to $40 million of common shares in company capital from the treasury to... Via Benzinga Cannabis Co. Kiaro Closes $3.75M Brokered Private Placement November 03, 2021 Kiaro Holdings Corp. (TSXV:KO) (OTC: Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Unicorn PharmaCann Could IPO Soon, Valued At $1.1B+ August 16, 2021 One of the largest private cannabis companies in the world could soon go public on the OTC Markets with a valuation of more than $1 bil... Via Benzinga Topics Cannabis Initial Public Offering Exposures Cannabis Securities Market Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.